Fundz

52North raised €6 million in a funding round co-led by KHP Ventures and Cedars-Sinai IP Co. to advance oncology-focused innovations and bring Neutrocheck® to market.

PRIVATEDec 03, 2024

Amount Raised

€6 Million

Round Type

Funding Round

CambridgeBiotechnologyHealth CareMedicalMedical Device

Investors

Jonathan MilnerRoland DiggelmannOkg CapitalCambridge Enterprise VenturesCancer Research HorizonsMacmillan Cancer SupportKHP VenturesCedars Sinai Intellectual Property Co.

Description

52North, a UK med-tech startup, secured €6 million in a funding round co-led by KHP Ventures and Cedars-Sinai Intellectual Property Co. This funding will help expand their product pipeline and enhance their offerings in oncology care, particularly through their Neutrocheck® device.

Quick answer

52North raised €6 Million in a Funding Round round, dated December 3, 2024. Investors: Jonathan Milner, Roland Diggelmann, Okg Capital, Cambridge Enterprise Ventures, Cancer Research Horizons, Macmillan Cancer Support, KHP Ventures and Cedars Sinai Intellectual Property Co. 52North is based in Cambridge, England, United Kingdom.

How much did 52North raise?
52North raised €6 Million in a Funding Round round on December 3, 2024.
Who invested in 52North?
Jonathan Milner, Roland Diggelmann, Okg Capital, Cambridge Enterprise Ventures, Cancer Research Horizons, Macmillan Cancer Support, KHP Ventures and Cedars Sinai Intellectual Property Co. are named as investors in this round.
What does 52North do?
52North is a UK med-tech startup focused on oncological advancements.
Where is 52North based and how big is it?
52North is based in Cambridge, England, United Kingdom. Fundz records about 14 employees.
Who are the decision-makers at 52North?
Fundz holds 2 contacts at 52North. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as 52North that raised within 45 days of this round, from Fundz verified event records.

  • Convergence Medical raised $5M (Series A) on January 16, 2025.
  • ErlySign raised $1.8M (Pre-Series A) on January 16, 2025.
  • Core Sound Imaging raised $80M on January 16, 2025.
  • Robeauté raised $28M (Series A) on January 13, 2025.
  • Field Medical raised $27M on January 8, 2025.
  • SpineGuard® raised $104K (Pre-Seed) on January 7, 2025.

Who to call at 52North, and when

A new round usually means 52North is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day 52North raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at 52North, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at 52North. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

52North

Location

Cambridge, England, United Kingdom

About

52North is a UK med-tech startup focused on oncological advancements. The company offers innovative solutions such as Neutrocheck®, a point-of-care device designed to monitor patients undergoing chemotherapy. With the goal of improving patient care, 52North aims to leverage AI and collaborations to enhance acute oncology care delivery. Their ongoing efforts are supported by strategic partners and healthcare leaders from both the UK and US.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment 52North raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for 52North's next move

See what Strategic adds

52North raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.